About Blend
Blend is a modern 503A mail-order compounding pharmacy. We work with medical clinics, telehealth companies, and independent practices.
Meet the people behind your prescriptions
We've scaled telemed companies, built compounding pharmacies, and launched software used by millions.
Dan has led pharmacy operations for trusted names in telehealth, compounding, and clinical care. He's built compounding pharmacies from conception to scale and served as VP of Pharmacy Operations at 9amHealth, Director of Pharmacy at Hims & Hers (NYSE: HIMS), and VP at Curexa. Dan brings deep expertise in customized formulations, fulfillment, and clinical quality.
Ben is the co-founder and former CEO of Apostrophe, a teledermatology and compounding pharmacy brand acquired by Hims & Hers (NYSE: HIMS) for $193m. Ben understands the operational and regulatory complexities of building a telehealth brand—and how the right pharmacy partner can unlock growth.
Ryan co-founded Apostrophe and led product, marketing, and operations through its growth and acquisition by Hims & Hers (NYSE: HIMS). Ryan brings a deep understanding of how modern clinics and telehealth brands can differentiate through thoughtful packaging, clear communication, and seamless pharmacy integration.
John is a technology leader with a track record of building scalable platforms for healthcare and consumer brands. He's held leadership roles at Regis (NYSE: RGS), Mindbody (acquired for $2B), and AI innovator Diffbot. John focuses on building pharmacy infrastructure that makes fulfillment faster, clearer, and easier to manage.
